Amdocs (DOX) Tops Q2 EPS by 2c; offers guidance

Amdocs (NASDAQ: DOX) reported Q2 EPS of $1.78, $0.02 better than the analyst estimate of $1.76. Revenue for the quarter came in at $1.17 billion versus the consensus estimate of $1.16 billion.

GUIDANCE:

Amdocs sees Q3 2026 EPS of $1.81-$1.87, versus the consensus of $1.89. Amdocs sees Q3 2026 revenue of $1.155-1.195 billion, versus the consensus of $1.176 billion.

For earnings history and earnings-related data on Amdocs (DOX) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• PreveCeutical closes second tranche of private placement for $245,000
• XORTX to voluntarily delist from TSX Venture Exchange